CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Planned sale Global Head of R&D sold 5,000 shares at $350.06 ($1,750,312)
- 4 Open-market sale Director sold 2,665 shares at $337.00 ($898,105)
- 4 Open-market sale Principal Accounting Officer sold 122 shares at $326.76 ($39,865)
- 4 Planned sale President and COO sold 89,794 shares at an average $304.56 ($27,347,635)
- 4 Planned sale SVP, General Counsel sold 11,013 shares at an average $300.45 ($3,308,877)
- 4 Open-market sale Chief Financial Officer sold 1,190 shares at $290.47 ($345,659)
- 4 Planned sale Global Head of R&D sold 4,300 shares at an average $302.65 ($1,301,375)
- 4 Open-market sale SVP, General Counsel sold 920 shares at $304.60 ($280,233)
- 4 Planned sale Global Head of R&D sold 700 shares at $300.00 ($210,000)
- 4 Planned sale Chief Executive Officer sold 27,802 shares at an average $253.38 ($7,044,591)
- 4 Open-market sale Global Head of R&D sold 1,028 shares at $260.00 ($267,280)
- 4 Open-market sale President and COO sold 1,363 shares at $260.00 ($354,380)
- 4 Planned sale Director sold 2,007 shares at an average $265.50 ($532,867)
- 4 Open-market sale Chief Executive Officer sold 3,174 shares at an average $261.61 ($830,360)
- 4 Open-market sale SVP, General Counsel sold 422 shares at $266.50 ($112,463)
- 4 Open-market sale Global Head of R&D sold 1,647 shares at an average $262.11 ($431,699)
- 4 Open-market sale President and COO sold 2,173 shares at an average $261.27 ($567,742)
- 4 Open-market sale Chief Executive Officer sold 5,140 shares at an average $263.33 ($1,353,520)
- 4 Open-market sale Principal Accounting Officer sold 134 shares at $258.36 ($34,620)
- 4 Grant or award SVP, General Counsel acquired 46,878 shares (grant or award)
Page 5 of 29 · 580 filings